Case Investigations

Blink Charging Company

September 9, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Blink Charging Company (“Blink” or the “Company”) (NASDAQ: BLNK).  A complaint has been filed on behalf of investors who purchased or otherwise acquired Blink common stock between March 6, 2020 and August 19, 2020 inclusive (the “Class Period”).

OneSpan Inc.

September 9, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of OneSpan Inc. (“OneSpan” or the “Company”) (NASDAQ: OSPN).  A complaint has been filed on behalf of investors who purchased or otherwise acquired OneSpan securities between May 9, 2018 and August 11, 2020 inclusive (the “Class Period”).

Qutoutiao Inc.

September 9, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Qutoutiao Inc. (“Qutoutiao” or the “Company”) (NASDAQ: QTT).  A complaint has been filed on behalf of investors who purchased or otherwise acquired Qutoutiao American Depositary Shares ("ADSs") pursuant and/or traceable to the registration statement or prospectus for the Company’s September 2018 initial public offering (the “IPO”) or purchased or otherwise acquired Qutoutiao securities between September 14, 2018 and July 15, 2020, inclusive (the “Class Period”).

American Electric Power Company

September 9, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of American Electric Power Company (“AEP” or the “Company”) (NYSE: AEP).  A complaint has been filed on behalf of investors who purchased publicly traded AEP securities between November 2, 2016 and July 24, 2020, inclusive (the “Class Period”).

Airbus SE

September 1, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Airbus SE (“Airbus” or the “Company”) (OTC: EADSY).  A complaint has been filed on behalf of investors that acquired Airbus securities between February 24, 2016 and July 30, 2020, inclusive (the “Class Period”).

STAAR Surgical Company

August 21, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA).  A complaint has been filed on behalf of investors that purchased or otherwise acquired STAAR common stock between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”).

GFL Environmental Inc.

August 21, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GFL Environmental Inc. (“GFL” or the “Company”) (NYSE: GFL).

Velocity Financial, Inc.

August 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Velocity Financial, LLC (“Velocity Financial” or the “Company”) (NYSE: VEL).  A complaint has been filed on behalf of purchasers of Velocity’s common stock pursuant and/or traceable to Velocity’s January 2020 initial public offering (“IPO”).

ProAssurance Corporation

August 5, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ProAssurance Corporation (“ProAssurance” or the “Company”) (NYSE: PRA).  A complaint has been filed on behalf of investors that purchased or otherwise acquired ProAssurance common stock between April 26, 2019 and May 7, 2020, inclusive (the “Class Period”).

Cheetah Mobile, Inc.

August 5, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Cheetah Mobile, Inc. (“Cheetah Mobile” or the “Company”) (NYSE: CMCM).  A complaint has been filed on behalf of investors that purchased or otherwise acquired Cheetah Mobile securities between March 25, 2019 and February 20, 2020, inclusive (the “Class Period”).

Brookdale Senior Living Inc.

August 5, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Brookdale Senior Living Inc. (“Brookdale” or the “Company”) (NYSE: BKD).  A complaint has been filed on behalf of investors that purchased or otherwise acquired Brookdale securities between August 10, 2016 and April 29, 2020, inclusive (the “Class Period”).

Ideanomics, Inc.

August 5, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ideanomics, Inc. (“Ideanomics”) (NASDAQ: IDEX).  A complaint has been filed on behalf of investors that acquired the common stock of Ideanomics between March 20, 2020 and June 25, 2020, inclusive (the “Class Period”).

Eastman Kodak Co.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eastman Kodak Co. (“Kodak” or the “Company”) (NYSE: KODK).

The GEO Group, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The GEO Group, Inc. (“GEO Group” or the “Company”) (NYSE: GEO).  A complaint has been filed on behalf of investors that purchased or otherwise acquired GEO Group securities between February 27, 2020 and June 16, 2020, inclusive (the “Class Period”).

Tufin Software Technologies Ltd.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Tufin Software Technologies Ltd. (“Tufin” or the “Company”) (NYSE: TUFN).

J2 Global, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of J2 Global, Inc. (“J2 Global” or the “Company”) (NASDAQ: JCOM). A complaint has been filed on behalf of investors that purchased or otherwise acquired the publicly traded securities of J2 Global between October 5, 2015 and June 29, 2020, inclusive (the “Class Period”).

Verrica Pharmaceuticals Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ: VRCA).  A complaint has been filed on behalf of investors that purchased Verrica securities between September 16, 2019 and June 29, 2020, inclusive (the “Class Period”).

Guidewire Software Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Guidewire Software Inc. (“Guidewire” or the “Company”) (NASDAQ: GWRE).  A complaint has been filed on behalf of investors that purchased Guidewire common stock between March 6, 2019 and March 4, 2020, inclusive (the “Class Period”).

Energy Recovery, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Energy Recovery, Inc. (“Energy Recovery” or the “Company”) (NASDAQ: ERII).  A complaint has been filed on behalf of investors that purchased Energy Recovery shares between August 2, 2017 and June 20, 2020, inclusive (the “Class Period”).

Vaxart, Inc.

July 27, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAW: VXRT).

Two Energy Harbor Power Plants

July 21, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FirstEnergy Corp. (“FirstEnergy” or the “Company”) (NYSE: FE) and its former subsidiary Energy Harbor Corp. (“Energy Harbor) (OTC: ENGH) .  Investors who purchased FirstEnergy or Energy Harbor securities may be affected.

Wirecard AG

June 19, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Wirecard AG (“Wirecard” or the “Company”) (OTC: WCAGY).

Chembio Diagnostics, Inc.

June 17, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims against Chembio Diagnostics, Inc. (“Chembio”) for violations of the federal securities laws.

Carnival Corporation

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Carnival Corporation (“Carnival” or the “Company”).  A complaint has been filed on behalf of investors that purchased or acquired Carnival common stock (NYSE: CCL) or American Depository Shares (NYSE: CUK) between September 26, 2019 and April 30, 2020, inclusive (the “Class Period”).

Hamilton Beach Brands

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Hamilton Beach Brands Holding Company (“Hamilton Beach” or the “Company”) (NYSE: HBB).  A complaint has been filed against the Company on behalf of investors that purchased or acquired Hamilton Beach securities between February 27, 2020 and May 8, 2020, inclusive (the “Class Period”).

Elanco Animal Health

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN).  A complaint has been filed on behalf of investors that purchased or acquired Elanco Animal securities between January 10, 2020 and May 6, 2020, inclusive (the “Class Period”).

Conn's Inc.

May 22, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Conn’s Inc. (“Conn’s” or the “Company”) (NASDAQ: CONN) that purchased Conn’s securities between September 3, 2019 and December 9, 2019, inclusive (the “Class Period”).

Hallmark Financial Services

May 19, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Hallmark Financial Services (“Hallmark Financial” or the “Company”) (NASDAQ: HALL) that purchased Hallmark Financial securities between March 5, 2019 and March 17, 2020, inclusive (the “Class Period”).

Recro Pharma, Inc.

May 11, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Recro Pharma, Inc. (“Recro Pharma” or the “Company”) (NASDAQ: REPH).  Investors who purchased Recro Pharma securities may be affected.

CNS Pharmaceurticals, Inc.

May 8, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CNS Pharmaceuticals, Inc. (“CNS” or the “Company”) (NASDAQ: CNSP).  Investors who purchased CNS securities may be affected.